The short-term business model at Lartbio is embryo production. Currently, the company can produce embryos up to 300 straws every year, which is sold to Livestock Farm Owners and Inseminators for $500 each. It also plans to produce and sell a new breed of cattle like a super-muscle cow or non-prion cattle simultaneously. There are additional plans to open exclusive steakhouses with these new breeds. At a midterm stage, the company plans to produce designer milk for human consumption. Each cow produces 8000kg of milk every year, which is worth $12000. The ultimate goal is to create a biosimilar drug product. The company needs $17 million for research and investment in constructing its farm overseas. The company is looking to expand and create a long-term market. Their target market is $1 million in Korea. Reportedly, the global market size for Humanized Milk is $8.6 billion.